Introduction
It has been well established that surgery on temporal lobe due to medically refractory epilepsy is an extremely effective treatment, which controls seizure in almost 60-80% of patients, 1,2 thereby leading to significant improvements in quality of life (QOL). Recent arouse of interest has shown that Seizure (2008) Summary It has been suggested that aim of the temporal lobe epilepsy surgery is twofold: first is to decrease seizure frequency and second is to improve quality of life without causing intolerable complications. The aim of this prospective, longitudinal clinical study is to report outcomes with respect to seizure, medication, employment and quality of life in short-and long-term follow-ups after resective temporal lobe epilepsy surgery.
Consecutively 63 patients who underwent resective temporal lobe epilepsy surgery between 1993 and 1994 were enrolled. Outcomes at 6 months, 2 and 12 years were evaluated and compared with pre-operative status. The mean follow-up of this study was 12.3 AE 0.6 years.
Results showed that rates of seizure freedom were 82.5, 76.2, and 70.8% at 6 months, 2 and 12 years, respectively. Significant reduction in antiepileptic drug dose at long-term follow-up was found when compared to baseline. Patients after surgery had net gain of employment and improved quality of life was seen in all seizure outcome groups after surgery. Seizure-free patients showed better quality of life than those who continued to have seizure.
Our results suggest that surgery leads to improvement in both seizure outcome and quality of life. Even years after the surgery, patients are still working, have reduced their medication load and have nearly normal life. # 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. evaluating surgical effectiveness depending solely on the seizure outcome is not sufficient since the reduction of seizure frequency itself cannot reflect the improvement of emotional and social well-being in epileptic patients. Thus, the ultimate goal of surgery is to improve the QOL. 3 Seizure cessation and/or significant reduction are shown to be correlated with improved QOL and especially seizure-free (SF) patients are likely to have better QOL. 4, 5 Over the last two decades, clinical studies have focused on QOL in patients who had been treated by medication 6, 7 or by surgery [8] [9] [10] and concluded that QOL and psychosocial outcomes should not be assessed any earlier than 2 years after surgery 11 or one study showed that patients who had surgery have normal life 3 years after surgery. 12 Unfortunately, most of the available data come from the studies assessing the patients at less than 5 years after surgery 8, 9, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] and there are only a few prospective studies concerning long-term outcome beyond 5 years. 4, 5, 10, [22] [23] [24] [25] In addition, there are very little data with respect to prospective clinical studies concerning comparison between pre-and post-surgery QOL beyond 5 years. 5, 23 There is only one recently published prospective clinical study, which aimed to compare 2 years seizure outcome and QOL with 10 years follow-up after surgery. 25 Patient's pre-operative data should be included in prospective studies since the comparison of postoperative status with the input provides better understanding on the effectiveness of the treatment that we performed. As far as we know, there has been no prospective clinical study specifically concerning the comparison of pre-and post-operative QOL at long term (i.e., presenting data with almost 12 years of follow-up) in patients who had temporal lobe epilepsy surgery due to intractable epilepsy.
The focus of the present prospective clinical study is to evaluate baseline and post-surgery QOL in patients who had been operated due to drugresistant temporal lobe epilepsy and to state the results obtained at 6 months (short term), 2 and 12 years (long term) after surgery.
Materials and methods

Patients
The study focused on the operated patients who had medically resistant temporal lobe epilepsy due to a variety of causes. In the spirit of a ''before-after'' study, the concern was to determine whether such operative success is associated with increase in QOL. The study was conducted at Montreal Neurological Institute (MNI), a tertiary care center with a longestablished multidisciplinary team of epilepsy specialists. Patients come to MNH from within and outside Canada. The patients referred to MNI for possible surgery have severe and complex seizure disorders, medically intractable for many years. The extensive evaluation process included discontinuation of antiepileptic drugs (AEDs) for electroencephalography studies, depth electrode monitoring of seizures in selected patients, neuropsychologic evaluation and, if indicated, amytal speech and memory testing and radiological investigation. All patients included in this study admitted to the epilepsy service at the MNI between 14 December 1993 and 6 October 1994. Sixty-three patients were included in this study. Our inclusion criteria were (a) confirmed diagnosis of epilepsy, with medically intractable seizures and no previous surgical treatment, (b) age at least 17 years, and (c) no history of chronic psychiatric illness or evidence of mental retardation. All data were available before surgery, at 6 months and 2 years follow-ups for all 63 patients, however, at 12 years after surgery, since 15 patients were lost to followup, 48 (76%) patients were assessed. Thus, in this study, 63 patients' data at 6 months and 2 years and 48 patients' data at 12 years after surgery were evaluated and compared to both each other and baseline. Baseline clinical and socio-demographic profiles are summarized in Table 1 .
Surgery
Surgical procedures in all patients were performed by the same surgeon (A.O.). The surgical techniques of selective amygdalohippocampectomy, corticoamygdalohippocampectomy and lesionectomy on temporal lobe have been described in detail elsewhere. 1, 2 
Histopathological study
Hippocampal and lesional tissues sufficient for histopathological diagnosis were available in all patients. The resected specimens were histopathologically examined with previously described techniques. 26 Majority of the patients were diagnosed as mesial temporal lobe epilepsy either gliosis or sclerosis (Table 1) .
Post-operative evaluation
Patients were discharged on therapeutic dosages of at least one first-line AED. The first follow-up was performed at 6 weeks following the surgery and 6 months in the first year and yearly thereafter, either through outpatient visits or telephone interviews. Outcome was assessed independently by the neurological and neurosurgical teams. All patients had MRI, scalp EEG and neuropsychologic evaluations during the follow-up periods. In this study, seizure outcome and QOL were evaluated at 6 months, 2 and 12 years post-operatively.
Seizure outcome
Outcome at 6-month and 2-year follow-ups in relation to seizure control was based on Engel's classification, using all 12 subclasses (modified Engel classification), 27 thus different from some other studies ''aura only'' was classified as ''not seizure-free'' (NSF) since it has been demonstrated that even ''only aura'' after surgery has negative impact on QOL. For categorical comparisons, this classification was divided into favorable [(Engel classes I and II)] and unfavorable [(Engel classes III and IV)] seizure outcomes. ''Seizure-free'' group in this study included only the patients who had been seizure-free since surgery (Engel Ia).
Quality of life assessment
In this study, quality of life inventory in epilepsy-10 (QOLIE-10) was used. The QOLIE-10 is a self-administered questionnaire designed for completion by patients alone and was derived from the QOLIE-31. 28 It consists of 10 questions designed to assess the patients' subjective rating of their memory, level of physical and mental well-being, energy, depression, worries about seizures and work, social limitations, and overall quality of life. Each item in the questionnaire is ranked on a scale of 1-5, the lower the score on the QOLIE-10, the better the QOL. The QOLIE-10 is specific for epilepsy and reliability and validity have recently been proved and found that it is rather reliable as compared with its longer version, the QOLIE-31.
29,30
Statistical analysis
The data were analyzed using SPSS computer software (SPSS Version 11.0.1; SPSS Inc., Chicago, IL). Tests of significance used were the ''Mann-Whitney U-test'' with exact probabilities corrected for ties; ''Kendall's b'' correlation coefficient corrected for ties, and for categorical variables x 2 was used. For the purpose of analysis, the data were split into those who were seizure-free and those who continued to have seizures or not seizure-free. We also used nonparametric analysis to compare differences between scores obtained at 6 months, 2 and 12 years. Results QOLIE-10 questionnaire was completed by 63 patients before 6 months and 2 years after the surgery. In 12 years after surgery, 48 (76%) patients completed the questionnaire by phone contact. Fifteen patients were lost to long-term follow-up: 13 patients were not contacted probably due to address or telephone number changes and 2 patients died (mothers told on the phone) due to non-epilepsy-related causes. The subject pool comprised 32 females and 31 males, with a mean age of 34.4 AE 11.3 years ( Table 1 ). The mean follow-up was 12.3 AE 0.6 years.
Seizure outcome
At 6 months, 2 and 12 years follow-ups, patients were included in favorable seizure outcome (FO) as follows: 61 (96.8%), 61 (96.8%), and 46 patients (95.8%), respectively. There was no statistically significant difference regarding FO between 2 and 12 years (x 2 , p = 0.08). A total of 52 (82.5%), 48 (76.2%), and 34 (70.8%) patients were completely SF (Engel Ia) without aura after tough questioning concerning of presence or absence of aura at 6 months, 2 and 12 years after surgery, respectively and no patients were left with a worse seizure frequency or severity following surgery (no Engel IVb). The difference between 2 and 12 years after surgery with respect to seizure freedom was statistically significant (x 2 , p = 0.04). The rate of seizure freedom showed a trend to decrease from 52 (82.5%) to 34 (70.8%) during follow-ups (Table 2) .
Medication outcome
At the MNI, reduction toward a cessation of AEDs is tailored to each individual; all patients' progress through an extended period of AED tapering before medication ceases. Table 2 demonstrates the AED use following surgery. As can be seen in Table 2 , the mean number of AEDs prescribed decreased with time and comparison between baseline and followups regarding dose reduction disclosed statistically significant difference (Mann-Whitney U-test; p = 0.0001) regardless of seizure outcome. Carbamazepine was the most prescribed AED followed by Phenytoin before and after surgery. AEDs dose significantly reduced at 2 years (Mann-Whitney U-test; p = 0.0001) and 12 years (Mann-Whitney U-test; p = 0.0001) compared to 6 months. However, although mean AEDs dose at 12 years was found to be lower than at 2 years after surgery, the difference did not reach significant level (MannWhitney U-test; p = 0.06). Of the 63, 20 (31.7%) patients no longer took AEDs at 2 years after surgery and all were SF. Of those 43 patients who continued to take AEDs, 28 (65.1%) were SF and 3 (6.9%) had only aura (Ib). At 12 years follow-up, 23 (47.9%) of 48 342
T. Tanriverdi et al. patients were off medication and all were SF. Two patients although did not have seizure refused to stop medication at long term. A better seizure outcome was associated with a higher rate of discontinuation or reduction of AEDs at short-term (6 months and 2 years) but not at long-term (12 years) follow-up. The comparison between SF patients and those with rare or frequent persistent seizures with respect to the AED regimen (discontinuation or reduction vs. no change or increase) was statistically significant at 6 months (Mann-Whitney U-test; p = 0.001) and at 2 years (Mann-Whitney U-test; p = 0.001) but not at 12 years (Mann-Whitney Utest; p = 0.17).
Employment outcome
Of the 63 patients, 16 (25.3%) were students at the time of surgery (Table 3) . Prior to surgery, 6 (9.5%) could not go to school due to epilepsy, 2 (3.2%) was going to school part-time and 8 (12.7%) were at the school full-time. The students who could not go to school before surgery were able to go to school 6 months after surgery. One and three students who were SF graduated from the university at 6 months and 2 years following surgery, respectively and begun to work full-time. By 12 years after surgery, all graduated from their schools. Regardless of seizure outcome, post-operative short-term (6 months and 2 years) and long-term (12 years) school status was significantly improved compared to baseline (x 2 ; p > 0.05). Shifts from part-time to full-time going to school were statistically significant regarding follow-ups (x 2 ; p > 0.05) and there was a significant difference between SF and NSF patients with respect to shift from part-time to full-time school (x 2 ; p > 0.05).
Before surgery, 22 (34.9%) lost their job due to seizure and 18 (28.5%) patients were working parttime or full-time. Employment was significantly improved compared to baseline regardless of seizure outcome (x 2 ; p > 0.05). In the same context, the shift from part-time to full-time working increased during follow-up and there was a statistically significant difference between follow-ups when compared to each other (x 2 ; p > 0.05). SF patients had higher employment rate than NSF patients at short-and long-term (12 years) followups and the difference was statistically significant in terms of employment rate (x 2 ; p > 0.05). The SF patients in general continued to work over time and shifted from part-time to full-time. At 12 years follow-up, although they had no seizure, 4 (8.3%) patients could not find job and 1 with SF lost job due to other reasons ( Table 3) .
Quality of life outcome
Overall QOL: regardless of seizure outcome Table 4 demonstrates mean (AEstandard deviations) scores of subscales in QOLIE-10 questionnaire before 6 months, 2 and 12 years after surgery. There was a trend to improve QOL after surgery, even at very early follow-up (6 months). The highest score (worst) was found in ''driving problems'' subscale of QOLIE-10 followed by ''overall QOL'' subscale, suggesting that seizure most commonly affects social functioning domain of patient's life before surgery. Regardless of seizure outcome, comparing baseline scores with the scores obtained at 6 months (Mann-Whitney U-test; p = 0.00001), 2 years
Epilepsy surgery and quality of life 343 (Mann-Whitney U-test; p = 0.00001), and 12 years (Mann-Whitney U-test; p = 0.00001) demonstrated significant differences in all items of the questionnaire (Fig. 1) . When we compare QOL outcomes obtained at 6 months and 2-year follow-up, a global decrease (better) QOL values at 2 years post-surgery was documented in almost all 10 items (Table 4) . However, there were no statistically significant differences regarding to social functioning (limitations in work and social life), memory problems, seizure worry (fear for having seizure again), and overall QOL (Mann-Whitney U-test; p > 0.05). When we compared early (6 months) follow-up with long-term (12 years) follow-up, all but ''overall QOL'' subscale showed lower (better) scores at 12 years; however, patients still felt limited energy, have problems with car driving, have fear for having seizures (MannWhitney U-test; p = 0.001). Interestingly, ''overall QOL'' subscale score at 12 years was not better than at 6 months and the difference was not significant (Mann-Whitney U-test; p = 0.001). Comparing 2 and 12 years disclosed interesting findings. QOLIE-10 subscales were significantly better at 12 years in only 2 subscales: patients noted that at 12 years they had less memory problems (Mann-Whitney Utest; p = 0.04), and perceived less mental sideeffects of AEDs (Mann-Whitney U-test; p = 0.02). The most common problem noted by the patients at 12 years was the problems in driving and the dif-
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T. Tanriverdi et al. Figure 1 Graphic representations of subscales of quality of life inventory epilepsy-10 (QOLIE-10) before and after surgery. Significant improvements in all QOL subscales were found in patients very early after 6 months and long term (2 and 12 years) following surgery ( p = 0.00001) compared to baseline. Furthermore, seizure-free (Ia) patients at 6 months ( p = 0.001), 2 and 12 years ( p = 0.002 and 0.016, respectively) after surgery showed significantly improved overall QOL score compared to patients who continued to have seizure. (For interpretation of the references to color in this artwork, the reader is referred to the web version of the article.)
ference was statistically significant compared to 2 years regarding ''problems with car driving'' subscale (Mann-Whitney U-test; p = 0.04). Other unexpected findings were that patients regardless of seizure outcome noted that they were depressed, felt less energetic and their ''overall QOL'' was not better 12 years than it was at 2 years after surgery although the differences did not reach significant level.
Seizure outcome and quality of life: seizure-free versus not seizure-free
At 6-month follow-up, SF patients showed lower score (better) than NSF patients in all 10 items of QOLIE-10 questionnaire. Comparing the subscales showed significant differences in 8 subscales (Mann-Whitney U-test; p > 0.05); however ''limited energy'' (Mann-Whitney U-test; p = 0.08) and ''physical side-effects'' scores (Mann-Whitney Utest; p = 0.09) did not show significant difference. The most common problem was found in car driving in patients who had seizure 6 months after surgery. At 2-year follow-up, in general speaking, all subscales showed lower (better) mean score in SF patients than those who continued to have seizure. In 9 subscales of the questionnaire, SF patients noted significantly better scores than those of NSF patients (Mann-Whitney U-test; p > 0.05) but they still felt limited energy (Mann-Whitney U-test; p = 0.012). Difficulties in memory and car driving were the two common problems that noted were by the patients at 2 years follow-up.
At long-term (12 years) follow-up, again SF patients showed better QOL than those who continued to have seizure in all aspects of QOLIE-10 questionnaire. However, 3 subscales including ''memory problems'' (Mann-Whitney U-test; p = 0.26), ''limitation in social life'' (Mann-Whitney U-test; p = 0.13), and ''physical side-effects'' of AEDs (Mann-Whitney U-test; p = 0.1) did not reach significant level between SF and NSF patients 12 years after surgery. The most common problem noted by the patients with seizure at 12 years was in car driving.
Medication and quality of life
A better QOL was associated with a higher rate of discontinuation or reduction of AEDs at 2 and 12 years after surgery. Patients who were off medication had lower (better) mean scores in all 10 items of QOLIE-10 compared to those who continued to use AEDs at both 2 and 12 years after surgery. At 2 years, patients who were off medication noted that they had significantly improved memory (Mann-Whitney U-test; p = 0.04), had less physical (Mann-Whitney U-test; p = 0.003) and mental (Mann-Whitney Utest; p = 0.004) side-effects and improved overall QOL (Mann-Whitney U-test; p = 0.01) compared to patients who were still on AEDs. At 12 years, patients who were off AEDs noted that they had more energy (Mann-Whitney U-test; p = 0.008), less driving problems (Mann-Whitney U-test; p = 0.02), less physical side-effects of AEDs (Mann-Whitney Utest; p = 0.006), and had significantly improved overall QOL (Mann-Whitney U-test; p = 0.04) compared to those who were still on AED medication.
Discussion
In this prospective clinical study, we have reported short-and long-term outcomes with respect to seizure, medication, employment, and QOL in consecutive patients who had temporal lobe surgery due to medically resistant epilepsy between 1993 and 1994, a mean follow-up of 12.3 years. Depending on present data, we could suggest that surgery has (1) improved seizure outcome; (2) decreased medication use; (3) caused net employment gain; and (4) improved overall QOL in patients with temporal lobe epilepsy.
Previous outcome studies regarding QOL after surgical treatment are prospective with short-term follow-up (1-2 years), 9, 13, 16 or retrospective with again short-term follow-ups. 8, 14, 15 Some studies compared surgically treated groups with nonsurgically treated groups 11, 12, 17, 20, 22 and some reported their results without comparing baseline data. 4, 10, 11 There have been only two clinical studies that reported outcomes regarding QOL at long-term follow-up. The first one was a clinical study comparing QOL between SF and NSF patients almost 10 years after surgery. 4 However, this study lacks baseline data and was retrospective in nature. 4 The second one reported outcomes with respect to seizure, AED use, and psychosocial outcomes almost 10 years after surgery. 25 This study compared long-term results with the 2-year follow-up, without comparing baseline. 25 Regardless of the limitations, longterm studies concerning QOL or other measures are more important than those of short-term studies and prospective rather than retrospective nature provides better understanding related to the course of the disease after surgery and to the effect of treatment that is performed. It has been clearly demonstrated that improvement in QOL after surgery requires at least 2 years being manifested 11 ; thereby, psychosocial outcomes should not be studied any time shorter than 2 years. Present study will be the first prospective study presenting long-term results (mean 12 years) in relation to seizure outcome, AED use, employment and QOL in pre-and post-operative periods.
The rate of seizure freedom in our series at different intervals after surgery is in accordance with other long-term studies. 4, 25, 31 In our study, we think that the actual rate of seizure freedom at short-and long-term follow-ups were reported since all subscales of Engel's classification was used and after meticulous questioning ''aura only'' was not included in NSF patients since it has been shown that even ''aura only'' has also negative effects on quality of life. 8 Seizure freedom rate decreased from 82.5 to 70.8% during time after surgery which was in accordance with a recently published metaanalysis study reported by Tellez-Zenteno et al. 31 who found an association between duration of follow-up and seizure outcome (i.e., the longer the follow-up, the poorer the seizure outcome). However, our results are in contrast with the long-term results reported by Asztely et al. 25 who reported sustained rate of seizure outcome from time after surgery. The discrepancy between our results and data reported by Asztely et al. 25 might be largely due to the patients who were included in this study had temporal and extratemporal lobe epilepsy. 25 In our series, patients had epilepsy coming from only temporal lobe and the majority were due to mesial temporal lobe. It has been well-known that course, surgical treatment and outcome in extratemporal lobe epilepsy are extremely different from temporal lobe epilepsy. 32 Nevertheless, our results lend support to the notion that temporal lobe epilepsy surgery leads to seizure freedom in a considerable number of patients, even at long-term follow-up.
Considering AEDs use, different results have been published. In some studies, it has been found that there is an inverse association between duration of follow-up and proportion of patients discontinuing AEDs 31 ; however, this notion is not supported by others 10, 25 and our results. AEDs use in our study showed an associated with better seizure outcome (the better the seizure outcome, the lesser the AEDs use). In present study, the proportion of SF patients who had stopped AED medication at 2 years (19 of 48 patients; 39.5%) and at 12 years (18 of 34 patients; 52.9%) was similar to that reported in other studies. 10, 25, 33 Actually, we do not have an explanation for the discrepancy between our results and some meta-analytic studies 31 but we can speculate that the difference may be due to the patients (15 patients in our study) who were lost to 12 years follow-up and we think that it is difficult to interpret AEDs use prospectively since decision on the discontinuation of AED is influenced by many factors (e.g., doctor, patient or family preferences). Taken together, our results suggest that temporal lobe epilepsy surgery has positive impact on AEDs use at long-term follow-up and seizure outcome is associated with reduction or discontinuation of AED use.
Several studies showed that unemployment is a major problem in patients with epilepsy 34 and surgery improved employment gain. 21, 25 Gainful employment is a good predictor of overall wellbeing and patient satisfaction post-operatively and, therefore, represents an important outcome for patients. However in some studies it has been reported that surgery does not make a significant contribution to the actual employment except for patients who already lost their job or already in part-time employment. 14, 35 On the other hand, a few studies have shown that patients who become SF are more likely to maintain their job and improve economic situation than those who had seizure. 14, 21, 25 This notion is supported by our results that SF patients were more likely to have been employed before surgery than in the other outcome groups, suggesting that they may be less disabled by their seizures and, therefore, would be more likely to have better post-surgery outcome and some patient had progressed from part-time to full-time employment. Significantly more previously unemployed people or people who lost their job due to epilepsy had found or regained their jobs in SF group, consistent with the findings from recent long-term studies. 21, 25 In contrast, only 42.5% of NSF patients were employed (part-and full-time) compared to 73.6% of SF patients after excluding retired patients and patients who could not find or lost their jobs due to other reasons 12 years after surgery. In fact we felt during survey of present study that some patients who were seizure-free and off medication at long term do not want to get job and this may influence the employment rate. Nevertheless, seizure outcome affects employment and SF patients are more likely to gain employment or at least maintain their economic conditions compared to NSF patients. Temporal lobe epilepsy surgery regardless of seizure outcome has led to net gain in employment at both short-and long-term follow-ups.
During the last two decades, epilepsy centers all over the world have begun to report different aspects of life evaluated by different types of methods designed specifically for epileptic patients following surgical or medical treatments. However, only in recent years, prospective clinical studies with five or more than five follow-ups appeared in the literature. 5, 23, 24 Up to date there have been only two longitudinal clinical, one retrospective (10.3 years follow-up) 4 and one prospective (12.4 years follow-up), 25 studies evaluating QOL in patients underwent epilepsy surgery. Different types of QOL questionnaire used in the clinical studies disclosed some differences in the results but the common notion is that seizure freedom is the key to success. In the present study, we used health-related QOLIE-10 questionnaire which was derived from formerly developed questionnaire for epilepsy, QOLIE-31. 28 The validity and reliability of QOLIE-10 compared to its former form have been well demonstrated. 29, 30 Our analysis shows that regardless of seizure outcome, QOL improves significantly immediately after epilepsy surgery compared to baseline and these improvements sustain at longterm follow-ups as reported previously. 5, 36 Even patients who had seizures after surgery showed better QOL than baseline. SF patients have always noted better scores than those who continued to have seizures at short term (6 months) and long term (2 and 12 years) following surgery. However, we have found that SF patients had still some problems such as they were less energetic, still had physical side-effects of AEDs even at 12 years after surgery. For individual basis, we have noted that if seizure persists, declines in QOL begin after earliest testing (6 months) and continue to decline to pre-surgical level. The explanation why patients feel that their QOL improved at early assessment is that it is possible that there is a feeling of relief after surgery, which was translated into improved QOL as suggested by others. 5 Comparing 6 months, 2 and 12 years to each other regardless of seizure outcome revealed interesting findings. When patients were asked ''how has the quality of your life been during the past 4 weeks? That is, how have things been going for you?'' The patients were asked to circle one number (ranging number 1: very well to 5: very bad). Comparison of short-to longterm data showed insignificant difference, suggesting that even after 12 years patients are not still happy. In our study, some patients who had no seizure and were not on medication complained of their families who restricted them to join their friends, to go somewhere alone, etc. These findings suggest that evaluating the aspects of life is not easy and is dependent on some other factors. Another interesting finding that we found was that at least 7 subscales of QOLIE-10 questionnaire did not show statistically significant difference between 2 and 12 years after surgery regardless of seizure outcome. Our findings are consistent with McLachlan et al. 11 who specifically noted that improvements in QOL require at least 2 years being manifested and Mikati et al. 12 who showed that normalization of QOL after epilepsy surgery requires 3 years since they showed QOL of the surgery patients was similar to that of healthy controls 3 years after surgery. When we consider our results obtained at 2 and 12 years, it seems logical that QOL would not continue to improve with continued seizure-free status beyond a certain level since as time goes on SF patients perceive themselves as ''cured'' and improvements reach the levels of general population. We think that reaching this ''ceiling effect'' at long-term or post-operative adjustment problems can arise as patients learn to live without chronic epilepsy; a concept described as the ''burden of normality'' at long term can explain why we did not find significant difference in majority aspects of questionnaire between 2 and 12 years. It is also notable that even best seizure outcome patients still have social limitations at 12 years led us to think the concept of ''burden of normality.'' All together, although different results are reported so far, our analysis supports the common notion that surgery causes improvements in QOL in patients with temporal lobe epilepsy and SF patients are more likely to have better life than those who continues to have seizure after surgery. QOL in patients with reduced numbers of seizures seems improved but to a lesser degree and have better QOL than they were before surgery.
Limitations
The authors acknowledge the limitations of this investigation. First, our sample size was modest and the results were not compared with those of a control (healthy population). Second, as in many prospective follow-up studies, there were patients lost to follow-up over time; 15 (23.8%) patients in our study at 12 years after surgery and this may represent a bias in participating subjects. Globally, the characteristics of the patients in whom we did not reach were similar to those of the patients in whom we were able to reach. Despite limitations, the value of our study lies in its prospective nature and long-term follow-up period after epilepsy surgery. Furthermore, a comparison of short-and long-term result with baseline is another value of our study since our study is the first prospective one comparing the data obtained at 12 years and baseline.
Conclusion
Surgery leads to improvement in both seizure outcome and quality of life. Even years after the surgery patients are still working, have reduced their medication load and have nearly normal life and it is clear that post-surgical seizure status is an essential outcome.
